Repository logo
  • Log In
    Log in via Symplectic to deposit your publication(s).
Repository logo
  • Communities & Collections
  • Research Outputs
  • Statistics
  • Log In
    Log in via Symplectic to deposit your publication(s).
  1. Home
  2. Faculty of Medicine
  3. Faculty of Medicine
  4. Predictors of rehospitalization in a naturalistic cohort of patients with bipolar affective disorder
 
  • Details
Predictors of rehospitalization in a naturalistic cohort of patients with bipolar affective disorder
File(s)
Predictors of rehospitalisation BD - IJP resub.docx (92.55 KB)
Accepted version
Author(s)
O'Hagan, M
Cornelius, V
Young, AH
Taylor, D
Type
Journal Article
Abstract
There has only been limited research into the predictors of readmission in bipolar disorder. We carried out a 1-year follow-up of patients discharged from a single mental health unit following admission for treatment of an acute bipolar episode. Of 519 patients followed up for 1 year, 167 (32.2%) were readmitted. There was no association between readmission and any drug regimen. Prescription of antidepressants at discharge was not associated with increased risk of readmission [odds ratio (OR): 0.99, 95% confidence interval (CI): 0.98–1.01]. Among demographic factors, only smoking (OR: 1.75, 95% CI: 1.14–2.75) and age range of 42–53 years (OR: 1.99, 95% CI: 1.15–3.43) conferred an increased risk of readmission. Individually optimized drug treatment regimens are equally effective in practice. It is not clear why smoking is associated with readmission.
Date Issued
2017-05-01
Date Acceptance
2017-05-01
Citation
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2017, 32 (3), pp.115-120
URI
http://hdl.handle.net/10044/1/48693
DOI
https://www.dx.doi.org/10.1097/YIC.0000000000000163
ISSN
0268-1315
Publisher
Wolters Kluwer Health, Inc.
Start Page
115
End Page
120
Journal / Book Title
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
Volume
32
Issue
3
Copyright Statement
© 2017 Wolters Kluwer Health, Inc. All rights reserved. This is a non-final version of an article published in final form in International Clinical Psychopharmacology Issue: Volume 32(3), May 2017, p 115–120, available at: https://dx.doi.org/10.1097/YIC.0000000000000163
Identifier
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398819700001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
Subjects
Science & Technology
Life Sciences & Biomedicine
Pharmacology & Pharmacy
Psychiatry
antidepressants
antipsychotics
bipolar disorder
mood stabilizers
smoking
ADJUNCTIVE ATYPICAL ANTIPSYCHOTICS
MULTIPLE-TREATMENTS METAANALYSIS
TREATMENT-ENHANCEMENT-PROGRAM
RANDOMIZED CONTROLLED-TRIALS
CLAIMS DATABASE ANALYSIS
PSYCHIATRIC-HOSPITALIZATION
COMPARATIVE EFFICACY
MAINTENANCE PHASE
MOOD STABILIZER
SMOKING
1701 Psychology
1115 Pharmacology And Pharmaceutical Sciences
Publication Status
Published
About
Spiral Depositing with Spiral Publishing with Spiral Symplectic
Contact us
Open access team Report an issue
Other Services
Scholarly Communications Library Services
logo

Imperial College London

South Kensington Campus

London SW7 2AZ, UK

tel: +44 (0)20 7589 5111

Accessibility Modern slavery statement Cookie Policy

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback